PathAI Secures $60M in Series B Funding Led by General Atlantic and Existing Investor General Catalyst
PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. The round was led by new investor General Atlantic, a leading global growth equity firm, with strong participation from General Catalyst and other existing investors. The new capital will fuel PathAI’s continued expansion as the company seeks to advance the medical discipline of pathology. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors as the company advances its mission of offering faster, safer, and more powerful solutions for the diagnosis and sub-typing of diseases like cancer.
General Atlantic, a leading global growth equity firm, announced today that Rob Perez, former President and CEO of Cubist Pharmaceuticals, Inc. has joined the firm as an Operating Partner. Based in the firm’s New York office, Mr. Perez will have a particular focus on the biopharma and life sciences sectors, using his expertise to identify new investment opportunities and support the growth of the firm’s existing investments. Mr. Perez will be a part of the General Atlantic’s Resources Group, providing strategic counsel to the firm’s investment teams and portfolio companies.
Today, Health and Human Services Deputy Secretary Eric Hargan announced the initial core participants of the Deputy Secretary’s Innovation and Investment Summit (DSIIS) and December 18, 2018 as the date of the first meeting. As announced on September 19, 2018, the DSIIS will be a yearlong collaboration between healthcare innovation and investment professionals and HHS personnel who will meet quarterly to discuss the innovation and investment landscape within the healthcare sector, emerging opportunities, and the government’s role in facilitating more investment and accelerated innovation.
Three leading oncology practices unite with partners in technology and finance to announce the launch of OneOncology, a patient-centric, physician-driven, and technology-powered company with a mission to improve the lives of everyone living with cancer.
Landmark Health (“Landmark” or the “Company”), a leading provider of in-home, risk-based medical care, is pleased to announce that General Atlantic, a leading global growth equity firm, has made a strategic investment in the Company.
Ginkgo Bioworks, the organism company, today announced the opening of Bioworks3–Ginkgo’s third foundry for prototyping and scaling engineered organisms. This expansion is supported by $275 million in a Series D round with participation from all previous investors, including Viking Global, Y Combinator’s Continuity Fund, and Cascade Investment, the private investment vehicle of William H. Gates III, as well as new investors, including General Atlantic, a leading global growth equity firm. This brings the company’s total funding to $429 million. The new foundry will bring the power of biology to new markets including pharmaceuticals, agriculture and textiles, and accelerate the timeline for bringing current projects to commercial scale.
General Atlantic, a leading global growth equity firm, announced today that Andy Slavitt, former Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) and the former Group Executive Vice President at Optum, will become a Special Advisor to General Atlantic. He will bring a special focus on healthcare investments in underserved populations.
General Atlantic, a leading global growth equity firm, announced today that Michelle Dipp, M.D., Ph.D., Co-Founder and former General Partner of Longwood Fund, has joined General Atlantic as a Managing Director in the firm’s New York office. Dr. Dipp will be a senior member of the firm’s Global Healthcare team and will focus on biopharma and life sciences investments.
Sonendo, Inc., a leading dental technology company, announced today that General Atlantic, a leading global growth equity firm, has made a strategic investment in the company. General Atlantic will be joining existing investors Fjord Ventures, OrbiMed Advisors LLC, Meritech Capital Partners, CVF LLC, and NeoMed to lead the company’s latest fundraising round valued at $50 million. In its next phase of growth, Sonendo plans to accelerate ongoing commercialization efforts and further expand and diversify its current product portfolio.
A Place for Mom, North America’s largest network connecting families to senior living service providers, announced today that it has entered into a definitive agreement to be acquired by Silver Lake, a global leader in technology investing, and General Atlantic, a leading global growth equity firm. The company is being sold by its previous investor, Warburg Pincus. General Atlantic and Silver Lake will own equal stakes in A Place for Mom, which will continue to be led by CEO Sean Kell and the company’s management team, who will remain meaningful shareholders in the business. Terms of the transaction were not disclosed.
Synaptive Medical, a leading medical device and technology company that pursues connections to transform the process of care, announced today that General Atlantic, a global growth equity firm, has made a strategic investment in the company. With over 35 years of experience investing in 250 growth companies and deep expertise in the healthcare and technology sectors, General Atlantic partners with entrepreneurs and management teams around the world to help them accelerate growth and become market leaders.
General Atlantic, a leading global growth equity firm, announced today that Eric Zhang, former Global Partner and Managing Director of The Carlyle Group, has joined General Atlantic as Managing Director and Head of China. Mr. Zhang will lead the firm’s investments in growth companies across China.